Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 31
Phase 41

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01215890Phase 4Completed
Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease
Crohn's DiseaseLow Bone Mineral Density
Principalinvestigator
NCT01261286Phase 1Completed
Drug-Disease Interaction in Crohn's Disease
Crohn's Disease
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Alberta

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00175292Phase 3PrincipalInvestigator

A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn's Disease.

Crohn's DiseaseInflammatory Bowel Disease
Completed
NCT01215890Phase 4PrincipalInvestigator

Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease

Crohn's DiseaseLow Bone Mineral Density
Completed
NCT01261286Phase 1PrincipalInvestigator

Drug-Disease Interaction in Crohn's Disease

Crohn's Disease
Completed

All 3 trials loaded